Fig. 3. Average total benefits of Strep-A vaccination across the six vaccination scenarios from 2022 to 2051 (in trillions of US$).

3% discount rate and VSLY evaluated at three times global GDP per capita. Global GDP per capita is equal to $11,000 (constant 2015 US$). The colored columns represent the average benefits across the six scenarios, while the black bars represent the variation in benefits across the different scenarios.